JULY 2024LIFE SCIENCES REVIEW6Homoeopathy as a branch of alternative medicine claims to stimulate the body's own healing power and restore the balance and harmony of the person. It has been witnessing a slew of innovations that significantly improve the quality and efficacy of remedies, opening up a universe of business opportunities for homoeopathic product suppliers. On that note, the global homoeopathy market is estimated to reach $15.53 billion in 2028 at a CAGR of 16.4 per cent. Fueling this growth is a slew of factors. The most notable among these is the European Union's act of implementing comprehensive guidelines for homoeopathic products, necessitating rigorous quality and safety assessments. Ensuring regulatory compliance is becoming increasingly crucial for homoeopathic product suppliers to establish trust and tap into international markets. Nanotechnology is another growth factor. It is increasing the solubility, stability, and bioavailability of homeopathic remedies, which is leading to nano remedies gaining immense popularity. Artificial intelligence is also being steadily applied to homoeopathy to enhance the accuracy, efficiency and consistency of the medicines. Increasing awareness through educational programs and collaborations with academic institutions for courses and seminars is further promoting homeopathic remedies.This edition of Life Sciences Review Europe brings recent developments in the homoeopathic products arena and insights into how companies can adapt to these disruptive trends fundamentally transforming the industry to ace their drug development game. It features thought leadership articles from industry experts, including Jessica Wilson Rayse, Associate Director of Product Management, Accugenix at Charles River Laboratories, discussing microbiological considerations for achieving drug manufacturing excellence. Ken Lee, General Manager and Region Head of Clinical Development, Asia Pacific at Syneos Health, shares a perspective on optimizing clinical drug development with a high-touch `human' approach. We hope this edition featuring the Top Homeopathic Products Suppliers in Europe in 2024 helps you build the partnership your organization needs to sharpen its competitive edge in the homeopathic industry. Let us know your thoughts!EDITORIALThe Future of Homeopathy is HereCopyright © 2024 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Email:sales@lifesciencesreview.comeditor@lifesciencesreview.commarketing@lifesciencesreview.com JULY - 01 - 2024, Vol 05, Issue - 20 (ISSN 2831-8331) Published by ValleyMedia, Inc.To subscribe to Life Sciences ReviewVisit www.lifesciencesreview.com Editorial StaffAaron PierceCarolynn WaltersShirley FaithRussell ThomasVisualizersRonald DonovanDisclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsJeremy WilliamsManaging Editoreditor@lifesciencesreview.comManaging EditorJeremy WilliamsHenry SmithClara Matthew
< Page 5 | Page 7 >